Genentech
The Department of Immunology at Genentech is seeking a Scientist with deep expertise in lung biology and immunology to uncover novel therapeutic targets for respiratory diseases. This role involves leading research projects on the cellular and molecular mechanisms of lung injury, chronic inflammation, and tissue repair, while advancing research-stage programs into early clinical development. The position requires utilizing state-of-the-art technologies and fostering collaborations across immunology, human genetics, and early clinical development.
Headquarters
South San Francisco, California, United States
Company Size
10001+ employees
Founded
1976
Genentech is a research-driven biotechnology company that develops medicines through breakthrough science to treat people with serious and life‑threatening diseases. It discovers, advances and manufactures biologic therapies — including monoclonal antibodies and targeted medicines — across oncology, immunology, neuroscience and other therapeutic areas, moving candidates through discovery and clinical trials. Founded in 1976 and now part of the Roche group, Genentech is known for its patient-centered focus and for translating deep science into transformative, widely used medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genentech.
Scientist 3, Lung Biology & Inflammation
1000 Genentech, Inc.
Postdoctoral Position
University of Southern Denmark
Postdoctoral Position
University of Southern Denmark
Postdoctoral Position
University of Southern Denmark
Postdoctoral Position
University of Southern Denmark
Senior Scientist I, Experimental & Systems Immunology
AbbVie